(Reuters) - Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at a $150 discount to the cost of the injector pen versions ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid Brendan McDermid/Reuters ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

The American pharmaceutical company has started selling higher doses of Zepbound, as it seeks to spur demand for the medicine ...

Investing.com - Eli Lilly (NYSE:LLY) announced on Tuesday that ... weight-loss drug at a roughly $150 discount to its injector pen versions. Shares in the group edged higher in early U.S. trading.

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling ... a discount of $150 compared to the injector pen versions, Reuters reported.